Annual CFO:
-$520.73M+$6.99M(+1.33%)Summary
- As of today, BBIO annual cash from operations is -$520.73 million, with the most recent change of +$6.99 million (+1.33%) on December 31, 2024.
- During the last 3 years, BBIO annual cash from operations has fallen by -$22.79 million (-4.58%).
- BBIO annual cash from operations is now -1186.12% below its all-time high of -$40.49 million, reached on December 31, 2017.
Performance
BBIO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$80.68M+$118.55M(+59.50%)Summary
- As of today, BBIO quarterly cash from operations is -$80.68 million, with the most recent change of +$118.55 million (+59.50%) on June 30, 2025.
- Over the past year, BBIO quarterly cash from operations has dropped by -$155.38 million (-208.00%).
- BBIO quarterly cash from operations is now -208.00% below its all-time high of $74.70 million, reached on June 30, 2024.
Performance
BBIO Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$655.81M-$155.38M(-31.05%)Summary
- As of today, BBIO TTM cash from operations is -$655.81 million, with the most recent change of -$155.38 million (-31.05%) on June 30, 2025.
- Over the past year, BBIO TTM cash from operations has dropped by -$240.93 million (-58.07%).
- BBIO TTM cash from operations is now -3553.32% below its all-time high of -$17.95 million, reached on March 31, 2018.
Performance
BBIO TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
BBIO Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +1.3% | -208.0% | -58.1% |
| 3Y3 Years | -4.6% | -164.9% | -46.9% |
| 5Y5 Years | -105.3% | +8.2% | -72.7% |
BBIO Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -24.1% | +1.3% | -208.0% | +63.3% | -62.7% | at low |
| 5Y | 5-Year | -105.3% | +1.3% | -208.0% | +63.3% | -72.7% | at low |
| All-Time | All-Time | -1186.1% | +1.3% | -208.0% | +63.3% | -3553.3% | at low |
BBIO Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$80.68M(+59.5%) | -$655.81M(-31.1%) |
| Mar 2025 | - | -$199.24M(-2.0%) | -$500.42M(+3.9%) |
| Dec 2024 | -$520.73M(+1.3%) | -$195.33M(-8.2%) | -$520.73M(-15.7%) |
| Sep 2024 | - | -$180.57M(-341.7%) | -$450.22M(-8.5%) |
| Jun 2024 | - | $74.70M(+134.0%) | -$414.88M(+31.2%) |
| Mar 2024 | - | -$219.54M(-75.9%) | -$602.93M(-14.3%) |
| Dec 2023 | -$527.72M(-25.8%) | -$124.82M(+14.1%) | -$527.72M(-6.4%) |
| Sep 2023 | - | -$145.23M(-28.1%) | -$496.14M(-2.1%) |
| Jun 2023 | - | -$113.35M(+21.5%) | -$486.08M(-20.6%) |
| Mar 2023 | - | -$144.32M(-54.8%) | -$403.18M(+3.9%) |
| Dec 2022 | -$419.49M(+15.8%) | -$93.24M(+31.0%) | -$419.49M(+8.8%) |
| Sep 2022 | - | -$135.16M(-343.8%) | -$460.15M(-3.0%) |
| Jun 2022 | - | -$30.45M(+81.0%) | -$446.54M(+12.1%) |
| Mar 2022 | - | -$160.63M(-20.0%) | -$507.80M(-2.0%) |
| Dec 2021 | -$497.93M | -$133.90M(-10.1%) | -$497.93M(-8.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$121.56M(-32.5%) | -$460.30M(+2.2%) |
| Jun 2021 | - | -$91.71M(+39.2%) | -$470.42M(-0.8%) |
| Mar 2021 | - | -$150.76M(-56.6%) | -$466.56M(-16.7%) |
| Dec 2020 | -$399.71M(-57.6%) | -$96.26M(+26.9%) | -$399.71M(-5.3%) |
| Sep 2020 | - | -$131.68M(-49.9%) | -$379.66M(-27.4%) |
| Jun 2020 | - | -$87.85M(-4.7%) | -$297.97M(-7.0%) |
| Mar 2020 | - | -$83.92M(-10.1%) | -$278.37M(-9.8%) |
| Dec 2019 | -$253.59M(-85.6%) | -$76.20M(-52.4%) | -$253.59M(-13.3%) |
| Sep 2019 | - | -$50.00M(+26.7%) | -$223.80M(-5.5%) |
| Jun 2019 | - | -$68.25M(-15.4%) | -$212.12M(-19.3%) |
| Mar 2019 | - | -$59.14M(-27.4%) | -$177.83M(-30.1%) |
| Dec 2018 | -$136.64M(-237.5%) | -$46.41M(-21.1%) | -$136.64M(-51.4%) |
| Sep 2018 | - | -$38.32M(-12.9%) | -$90.23M(-73.8%) |
| Jun 2018 | - | -$33.96M(-89.2%) | -$51.91M(-189.2%) |
| Mar 2018 | - | -$17.95M | -$17.95M |
| Dec 2017 | -$40.49M | - | - |
FAQ
- What is BridgeBio Pharma, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. annual cash from operations year-on-year change?
- What is BridgeBio Pharma, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. quarterly cash from operations year-on-year change?
- What is BridgeBio Pharma, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. TTM cash from operations year-on-year change?
What is BridgeBio Pharma, Inc. annual cash from operations?
The current annual cash from operations of BBIO is -$520.73M
What is the all-time high annual cash from operations for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high annual cash from operations is -$40.49M
What is BridgeBio Pharma, Inc. annual cash from operations year-on-year change?
Over the past year, BBIO annual cash from operations has changed by +$6.99M (+1.33%)
What is BridgeBio Pharma, Inc. quarterly cash from operations?
The current quarterly cash from operations of BBIO is -$80.68M
What is the all-time high quarterly cash from operations for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high quarterly cash from operations is $74.70M
What is BridgeBio Pharma, Inc. quarterly cash from operations year-on-year change?
Over the past year, BBIO quarterly cash from operations has changed by -$155.38M (-208.00%)
What is BridgeBio Pharma, Inc. TTM cash from operations?
The current TTM cash from operations of BBIO is -$655.81M
What is the all-time high TTM cash from operations for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high TTM cash from operations is -$17.95M
What is BridgeBio Pharma, Inc. TTM cash from operations year-on-year change?
Over the past year, BBIO TTM cash from operations has changed by -$240.93M (-58.07%)